Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn more
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORE
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsMany drugs have multiple indications which may offer commercial opportunities but also present strategic and operational challenges, such as different levels of investment, various layers of regulations and resource allocation.
In this case study, a mid-size biopharma (EBP) company developed a new oncology drug formulation but needed to prioritize an indication to achieve market approval. The company sought IQVIA's support to perform an independent assessment and select an indication which thereafter aligns with the company's decision.
IQVIA created a roadmap, incorporated data figures and tapped into their team of internal disease and biomedical experts, completing the evaluation in a shorter timeframe.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
